June 16, 2013 at 18:50 PM EDT
Amgen share buybacks, drugs may fuel more stock gains - Barron's
June 16 (Reuters) - Amgen Inc, the world's largest biotechnology company, has plenty of room to grow despite a 43 percent jump in its share price over the past year, thanks to cost cuts, newer drugs and hefty share buybacks, Barron's said.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here